查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1703135

2025年全球临床诊断市场报告

Clinical Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年临床诊断市场规模将强劲成长。到 2029 年，这一数字将成长至 1,085.8 亿美元，年复合成长率（CAGR）为 7.3%。预测期内的成长动力包括对疾病早期检测的需求不断增加、医疗保健基础设施的扩大、对研发的投资不断增加、对分子诊断的需求不断增加以及与文明病的患病率不断上升。预测期内的关键趋势包括技术进步、数位病理学、人工智慧、穿戴式健康设备和远端医疗。

慢性病盛行率的上升预计将推动临床诊断市场的成长。慢性疾病需要持续的医疗管理，并且往往因不健康的生活方式、社会经济差距和老化而加剧，包括心臟病、糖尿病和癌症等疾病。准确的诊断、疾病监测、治疗管理、併发症的早期发现、个人化医疗、风险评估和病患教育变得越来越重要。例如，美国国家生物技术资讯中心（NCBI）预测，到2050年，50岁以上患有慢性病的人数将增加99.5%，从2020年的7,152万人增加到1.4266亿人。发病率的不断上升刺激了对临床诊断的需求。

临床诊断市场的主要企业集中在创新产品，例如有助于对固态肿瘤进行全面基因组分析的先进液态切片检测。液态切片检测是一种微创检测，透过分析血液样本来识别癌症相关的生物标记物，例如循环性肿瘤细胞(CTC) 和循环肿瘤 DNA (ctDNA)。这些检测为诊断、治疗监测和个人化医疗提供了宝贵的见解。例如，2023 年 11 月，Illumina 推出了 TruSight(TM) Oncology 500 ctDNA v2，液态切片检测，旨在提供固态肿瘤的详细基因组分析。该检测能够准确检测基因突变和改变，提供全面的分子图谱，以增强个人化治疗策略并支持及时的临床决策。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情和经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球临床诊断PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球临床诊断市场：成长率分析
  • 全球临床诊断市场表现：规模与成长，2019-2024
  • 全球临床诊断市场预测：规模与成长，2024-2029，2034
  • 全球临床诊断总目标市场（TAM）

第六章 市场细分

  • 全球临床诊断市场按测试类型划分：绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 实验室测试
  • 影像检查
  • 其他的
  • 全球临床诊断市场（按产品、效能和预测）2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 试剂
  • 其他的
  • 全球临床诊断市场按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院检查室
  • 诊断实验室
  • 就地检验
  • 其他的
  • 全球临床诊断市场、实验室测试细分、按类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 血液检查
  • 尿液检查
  • 基因检测
  • 切片检查和细胞学检查
  • 全球临床诊断市场、影像检查细分市场、类型、绩效及预测（2019-2024 年、2024-2029 年、2034 年）
  • X射线
  • MRI（磁振造影）
  • 电脑断层扫描（电脑断层扫描）
  • 超音波
  • PET扫描（正子断层扫描）
  • 全球临床诊断市场及其他检测细分市场，依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 分子诊断
  • 就地检验
  • 妊娠试验
  • 过敏测试

第七章 区域和国家分析

  • 全球临床诊断市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球临床诊断市场（依国家/地区划分）、绩效及预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 临床诊断市场：竞争格局
  • 临床诊断市场：公司简介
    • Siemens Healthineers
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation

第31章 其他大型创新企业

  • FUJIFILM Corporation
  • Becton, Dickinson and Company
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Grifols SA
  • Sonic Healthcare Limited
  • Hologic Inc.
  • Illumina Inc.
  • PerkinElmer Inc.
  • bioMerieux SA
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation
  • QIAGEN NV
  • Ortho Clinical Diagnostics

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年临床诊断市场：提供新机会的国家
  • 2029年临床诊断市场：细分领域带来新机会
  • 2029年临床诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r29795

Clinical diagnostics involves the identification, diagnosis, and monitoring of diseases or medical conditions through a variety of laboratory tests, imaging techniques, and other diagnostic tools. This process includes analyzing and interpreting patient samples, medical history, and clinical data to provide accurate and timely information essential for diagnosing, treating, and managing diseases.

The primary types of clinical diagnostic tests are lab tests, imaging tests, and other diagnostic procedures. Lab tests are performed on samples such as blood, urine, or tissue to detect diseases, monitor health conditions, or assess the effectiveness of treatments. The products used in clinical diagnostics consist of instruments, reagents, and other related items. These diagnostic tools are employed by various end users, including hospital laboratories, diagnostic laboratories, point-of-care testing facilities, and other healthcare settings.

The clinical diagnostics market research report is one of a series of new reports from The Business Research Company that provides clinical diagnostics market statistics, including clinical diagnostics industry global market size, regional shares, competitors with a clinical diagnostics market share, detailed clinical diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the clinical diagnostics industry. This clinical diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical diagnostics market size has grown strongly in recent years. It will grow from $76.27 billion in 2024 to $81.91 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to a rise in the incidence of chronic diseases, a rise in the use of point-of-care diagnostic products, an increasing number of tests due to the steady increase in patients, funding by governments, increasing demand for personalized medicine, and increasing geriatric population.

The clinical diagnostics market size is expected to see strong growth in the next few years. It will grow to $108.58 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing demand for early disease detection, expanding healthcare infrastructure, increasing investments in research and development, growing demand for molecular diagnostics, and rising prevalence of lifestyle-related diseases. Major trends in the forecast period include technological advancements, digital pathology, artificial intelligence, wearable health devices, and telemedicine.

The rising incidence of chronic diseases is expected to drive growth in the clinical diagnostics market. Chronic diseases, which require ongoing medical management and are often worsened by unhealthy lifestyles, socioeconomic disparities, and aging populations, include conditions such as heart disease, diabetes, and cancer. Accurate diagnosis, disease monitoring, treatment management, early detection of complications, personalized medicine, risk assessment, and patient education are becoming increasingly critical. For instance, the National Center for Biotechnology Information (NCBI) has projected that the number of individuals aged 50 and above with chronic illnesses will increase by 99.5% by 2050, growing from 71.52 million in 2020 to 142.66 million. This rising incidence is fueling the demand for clinical diagnostics.

Key players in the clinical diagnostics market are focusing on innovative products, such as advanced liquid biopsy assays, which facilitate comprehensive genomic profiling of solid tumors. Liquid biopsy assays are minimally invasive tests that analyze blood samples to identify cancer-related biomarkers, including circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA). These assays offer valuable insights for diagnosis, treatment monitoring, and personalized medicine. For example, in November 2023, Illumina Inc. introduced the TruSight(TM) Oncology 500 ctDNA v2, a liquid biopsy assay designed to provide detailed genomic profiling of solid tumors. This assay enables precise detection of genetic mutations and alterations, enhancing personalized treatment strategies by offering comprehensive molecular profiles and supporting timely clinical decisions.

In May 2022, BioMerieux acquired Specific Diagnostics to bolster its rapid antimicrobial susceptibility testing capabilities. This acquisition aims to strengthen BioMerieux's role in addressing antimicrobial resistance and improving patient outcomes in clinical microbiology. Specific Diagnostics, based in the US, is known for its innovations in clinical diagnostics, particularly in microbiology.

Major companies operating in the clinical diagnostics market are Siemens Healthineers, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, FUJIFILM Corporation, Becton, Dickinson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Grifols S.A., Sonic Healthcare Limited, Hologic Inc., Illumina Inc., PerkinElmer Inc., bioMerieux S.A., Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Ortho Clinical Diagnostics, BioReference Laboratories Inc., NeoGenomics Laboratories Inc.

North America was the largest region in the clinical diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical diagnostics market includes revenues earned by entities by providing services such as genetic testing, molecular diagnostics, pathology services, microbiology testing, and immunology testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The clinical diagnostics market also includes sale of imaging devices, laboratory analyzers, point-of-care testing devices, endoscopy equipment, and respiratory diagnostic devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test: Lab Test; Imaging Test; Other Tests
  • 2) By Product: Instruments; Reagents; Other Products
  • 3) By End User: Hospital Laboratory; Diagnostic Laboratory; Point-Of-Care Testing; Other End Users

Subsegments

  • 1) By Lab Test: Blood Tests; Urine Tests; Genetic Tests; Biopsy And Cytology Tests
  • 2) By Imaging Test: X-Ray; Mri (Magnetic Resonance Imaging); Ct Scan (Computed Tomography); Ultrasound; Pet Scan (Positron Emission Tomography)
  • 3) By Other Tests: Molecular Diagnostics; Point-Of-Care Tests; Pregnancy Tests; Allergy Tests
  • Companies Mentioned: Siemens Healthineers; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Diagnostics Market Characteristics

3. Clinical Diagnostics Market Trends And Strategies

4. Clinical Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Clinical Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Clinical Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Clinical Diagnostics Market Growth Rate Analysis
  • 5.4. Global Clinical Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Clinical Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Clinical Diagnostics Total Addressable Market (TAM)

6. Clinical Diagnostics Market Segmentation

  • 6.1. Global Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lab Test
  • Imaging Test
  • Other Tests
  • 6.2. Global Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents
  • Other Products
  • 6.3. Global Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Laboratory
  • Diagnostic Laboratory
  • Point-Of-Care Testing
  • Other End Users
  • 6.4. Global Clinical Diagnostics Market, Sub-Segmentation Of Lab Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Tests
  • Urine Tests
  • Genetic Tests
  • Biopsy And Cytology Tests
  • 6.5. Global Clinical Diagnostics Market, Sub-Segmentation Of Imaging Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • X-Ray
  • MRI (Magnetic Resonance Imaging)
  • CT Scan (Computed Tomography)
  • Ultrasound
  • PET Scan (Positron Emission Tomography)
  • 6.6. Global Clinical Diagnostics Market, Sub-Segmentation Of Other Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Diagnostics
  • Point-Of-Care Tests
  • Pregnancy Tests
  • Allergy Tests

7. Clinical Diagnostics Market Regional And Country Analysis

  • 7.1. Global Clinical Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Clinical Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Clinical Diagnostics Market

  • 8.1. Asia-Pacific Clinical Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Clinical Diagnostics Market

  • 9.1. China Clinical Diagnostics Market Overview
  • 9.2. China Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Clinical Diagnostics Market

  • 10.1. India Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Clinical Diagnostics Market

  • 11.1. Japan Clinical Diagnostics Market Overview
  • 11.2. Japan Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Clinical Diagnostics Market

  • 12.1. Australia Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Clinical Diagnostics Market

  • 13.1. Indonesia Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Clinical Diagnostics Market

  • 14.1. South Korea Clinical Diagnostics Market Overview
  • 14.2. South Korea Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Clinical Diagnostics Market

  • 15.1. Western Europe Clinical Diagnostics Market Overview
  • 15.2. Western Europe Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Clinical Diagnostics Market

  • 16.1. UK Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Clinical Diagnostics Market

  • 17.1. Germany Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Clinical Diagnostics Market

  • 18.1. France Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Clinical Diagnostics Market

  • 19.1. Italy Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Clinical Diagnostics Market

  • 20.1. Spain Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Clinical Diagnostics Market

  • 21.1. Eastern Europe Clinical Diagnostics Market Overview
  • 21.2. Eastern Europe Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Clinical Diagnostics Market

  • 22.1. Russia Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Clinical Diagnostics Market

  • 23.1. North America Clinical Diagnostics Market Overview
  • 23.2. North America Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Clinical Diagnostics Market

  • 24.1. USA Clinical Diagnostics Market Overview
  • 24.2. USA Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Clinical Diagnostics Market

  • 25.1. Canada Clinical Diagnostics Market Overview
  • 25.2. Canada Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Clinical Diagnostics Market

  • 26.1. South America Clinical Diagnostics Market Overview
  • 26.2. South America Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Clinical Diagnostics Market

  • 27.1. Brazil Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Clinical Diagnostics Market

  • 28.1. Middle East Clinical Diagnostics Market Overview
  • 28.2. Middle East Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Clinical Diagnostics Market

  • 29.1. Africa Clinical Diagnostics Market Overview
  • 29.2. Africa Clinical Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Clinical Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Clinical Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Clinical Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Clinical Diagnostics Market Competitive Landscape
  • 30.2. Clinical Diagnostics Market Company Profiles
    • 30.2.1. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Clinical Diagnostics Market Other Major And Innovative Companies

  • 31.1. FUJIFILM Corporation
  • 31.2. Becton, Dickinson and Company
  • 31.3. Laboratory Corporation of America Holdings
  • 31.4. Quest Diagnostics Incorporated
  • 31.5. Grifols S.A.
  • 31.6. Sonic Healthcare Limited
  • 31.7. Hologic Inc.
  • 31.8. Illumina Inc.
  • 31.9. PerkinElmer Inc.
  • 31.10. bioMerieux S.A.
  • 31.11. Sysmex Corporation
  • 31.12. Bio-Rad Laboratories Inc.
  • 31.13. Bruker Corporation
  • 31.14. QIAGEN N.V.
  • 31.15. Ortho Clinical Diagnostics

32. Global Clinical Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Diagnostics Market

34. Recent Developments In The Clinical Diagnostics Market

35. Clinical Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Clinical Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Clinical Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Clinical Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer